United States - English - NLM (National Library of Medicine)

puretek corporation - thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), niacin (unii: 2679mf687a) (niacin - unii:2679mf687a), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), ferrous fumarate (unii: r5l488ry0q) (ferrous c - thiamine 3 mg - prenatal + dha™ is indicated to provide vitamin/mineral and dha omega-3 fatty acid supplement to women throughout pregnancy, during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years. prenatal + dha™ may be beneficial in improving the nutritional status of women prior to conception. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

United States - English - NLM (National Library of Medicine)

merit pharmaceutical - thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), dexpanthenol (unii: 1o6c93ri7z) (dexpanthenol - unii:1o6c93ri7z), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4) - thiamine hydrochloride 100 mg in 1 ml - indications and usage:   in disorders requiring parenteral administration of vitamins, i.e. pre- and post-operative treatment, when requirements are increased as in fever, severe burns, increased metabolism, pregnancy, gastrointestinal disorders interfering with intake or absorption of vitamins, prolonged or wasting diseases, alcoholism and where other deficiencies exist. contraindications: sensitivity to the ingredients listed.

United States - English - NLM (National Library of Medicine)

eckson labs, llc - pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204), calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), magnesium (unii: i38zp9992a) (magnesium - unii:i38zp9992a), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z), sodium selenate (unii: 5dqp25600a) (selenate ion - - pyridoxine hydrochloride 50 mg - this product is a gluten-free prescription regimen of prenatal multi-vitamin, multi-mineral and omega fatty acid supplements indicated for use in improving the nutritional status of women throughout pregnancy and in the post-natal period for both lactating and non-lactating mothers. this product is also useful in improving the nutritional status prior to conception. this product is contraindicated in patients with known hypersensitivity to any of the ingredients, including fish or fish oil.

United States - English - NLM (National Library of Medicine)

benard industries inc - thiamine hydrochloride (unii: m572600e5p) (thiamine ion - unii:4abt0j945j), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), cyanocobalamin (unii: p6yc3eg204) (cyanocobalamin - unii:p6yc3eg204) - thiamine hydrochloride 100 mg

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - thiamine hydrochloride, quantity: 5 mg/ml; riboflavine sodium phosphate, quantity: 2.5 mg/ml; nicotinamide, quantity: 50 mg/ml; dexpanthenol, quantity: 10 mg/ml; pyridoxine hydrochloride, quantity: 25 mg/ml - injection, solution - excipient ingredients: disodium edetate; water for injections - b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. patients requiring parenteral b vitamin therapy who cannot tolerate intramuscular injections. 5. recovery from beriberi and wernicke's syndrome as a result of vitamin b1 deficiency. please note that iv b-dose 2ml injection does not contain sufficient thiamine for acute treatment of wernicke's syndrome. 6. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2 and b6. 7. peripheral neuritis caused by vari

Australia - English - Department of Health (Therapeutic Goods Administration)

orthomolecular medisearch laboratories pty ltd trading as biological therapies - thiamine hydrochloride, quantity: 10 mg/ml; riboflavine sodium phosphate, quantity: 2.5 mg/ml; pyridoxine hydrochloride, quantity: 5 mg/ml; dexpanthenol, quantity: 2.5 mg/ml; nicotinamide, quantity: 25 mg/ml; cyanocobalamin, quantity: 0.5 mg/ml - injection, solution - excipient ingredients: water for injections - b vitamin deficiencies may exist that are unable to be corrected by oral intake and in these cases parenteral administration may be preferable. oral administration of b vitamins may be insufficient in; alcoholism, pernicious anaemia, malabsorption disorders, gastrectomy, gastrointestinal pathologies and debilitated and elderly patients. commonly, several b vitamin deficiencies may occur similtaneously. specific indications include: 1. rapid saturation of the b group vitamins. 2. when oral administration is not feasible or appropriate. 3. for alcoholic, debilitated and elderly patients when their diet is inadequate. 4. recovery from beriberi and wernicke's syndrome as a result of vitamin b1 deficiency. please note that b-dose 2ml injection does not contain sufficient thiamine for acute treatment of wernicke's syndrome. 5. pellagra as a result of vitamin b3 deficiency. patients with pellagra may have a concurrent deficiency of b1, b2, b6 and b12. 6. peripheral neuritis caused by various b group deficiencies. 7.

United States - English - NLM (National Library of Medicine)

agri laboratories, ltd. - thiamine (unii: x66nso3n35) (thiamine ion - unii:4abt0j945j), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), dexpanthenol (unii: 1o6c93ri7z) (dexpanthenol - unii:1o6c93ri7z), riboflavin 5'-phosphate sodium (unii: 20rd1dzh99) (flavin mononucleotide - unii:7n464ure7e) - thiamine 1.25 mg in 1 ml - for animal use only keep out of reach of children indications for us as a supplemental source of a complex vitamins in cattle, swine and sheep.

Philippines - English - FDA (Food And Drug Administration)

jtsr pharmacy - thiamine mononitrate , pyridoxine hydrochloride , cyanocobalamine - capsule - 100mg + 5mg + 50mcg

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

watson`s personal care stores sdn bhd - thiamine hydrochloride; pyridoxine hydrochloride; cyanocobalamine; nicotinamide; calcium d-pantothenate; d-biotin; riboflavin 5-phosphate sodium; zinc sulphate monohydrate; calcium carbonate; magnesium carbonate; ascorbic acid (vitamin c); folic acid -

Philippines - English - FDA (Food And Drug Administration)

pt merck tbk.; importer: procter & gamble philippines, inc.; distributor: n/a - neurobion forte - solution for injection (im) - formulation: each ampoule i contains: thiamine hydrochloride (vitamin b1)-100mg pyridoxine hydrochloride (vitamin b6)-100 mg each ampoule ii contains: cyanocobalamin (vitamin b12)-5 mg